Article content continued

The third-party report, according to Liberty, concluded that the allegation against Neufeld “was not supported by available evidence and appeared to be based upon erroneous filings.”

Neufeld, who remains a member of Aphria’s board, did not respond to a request for comment on the conclusions of Liberty’s third-party report.

Short-seller Nate Anderson of Hindenburg Research told the Financial Post in an e-mailed statement that “despite declaring the report to be inaccurate, Liberty Health Sciences highlighted a total of zero inaccuracies except for the company’s own inaccurate filing. Four directors have since resigned, which should speak volumes.”

Liberty Health Sciences highlighted a total of zero inaccuracies except for the company’s own inaccurate filing. Four directors have since resigned, which should speak volumes. Nate Anderson of short seller Hindenburg Research

In the same press release, Liberty Health said it would be embarking upon “strategic changes” to the makeup of its board — the company announced the resignation of John Hick and Ian McKinnon for “personal reasons related to the increased uncertainty regarding cross-border travel into the U.S.”

Hick, a veteran executive of the junior mining industry, and McKinnon, who was involved in the tech industry in the late 1990s and early 2000s, had just joined Liberty’s board in January.

McKinnon had replaced Neufeld as chairman of Liberty while Hick had replaced Aphria co-founder John Cervini.

In a press release dated Jan. 21, Liberty Health CEO George Scorsis had applauded McKinnon and Hick’s appointments for “enhancing independence at the Board level,” saying that the additions “underscore our commitment to strengthening our corporate governance.”

Neither Hick nor McKinnon could be reached for comment.

The third-party report was produced by Grassi & Co., an American consulting firm that deals largely with the cannabis industry.

It has not published the third-party report in full and did not respond to a request for comment.

Aphria too, has hired a third-party investigator to look into short-seller allegations against the company. The conclusions of that investigation have yet to be released by the company and no date has been announced.